Journals / Türk Toraks Dergisi / 2010 / Cilt: 11 - Sayı: 4

One patient, three malignancy:Hodgkin lymphoma, maltoma, lung cancer

Bir hasta üç malignite: Hodgkin lenfoma, maltoma, akciğer kanseri

Pages
187–190
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We want to present this case with literature reviews, as lymphoma, MALToma and carcinoma in the same patient is extremely rare.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A sixty-three-year-old man who had had Hodgkin lymphoma twenty years earlier and laryngeal mucosa associated lymphatic tissue lymphoma (MALToma) two years earlier and had been treated with radiotherapy and chemotherapy was admitted to our ward with cough and hemoptysis.
📊
Key Findings & Data:Physical examination revealed decreased breath sounds on the left hemitorax incomparison to the right.
💡
Conclusion & Impact:We want to present this case with literature reviews, as lymphoma, MALToma and carcinoma in the same patient is extremely rare.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

A sixty-three-year-old man who had had Hodgkin lymphoma twenty years earlier and laryngeal mucosa associated lymphatic tissue lymphoma (MALToma) two years earlier and had been treated with radiotherapy and chemotherapy was admitted to our ward with cough and hemoptysis. Physical examination revealed decreased breath sounds on the left hemitorax incomparison to the right. On chest x-ray and thoracic CT, at the left hilar region, there was a 6x5x5cm-sized, malignant-appearing mass with invasion to the hilar vascular structures. An endobronchial lesion was seen on fiberoptic bronchoscopy. The histology of the biopsy specimen was reported as squamous cell carcinoma. The patient was treated with chemotherapy and radiotherapy with the diagnosis of stage 3B lung carcinoma and is still on treatment. We want to present this case with literature reviews, as lymphoma, MALToma and carcinoma in the same patient is extremely rare.

Özet

Yirmi yıl önce Hodgkin lenfoma tanısı ve iki yıl önce larinks mukoza ile ilişkili lenfatik doku lenfoması (MALToma) tanısı ile radyoterapi, kemoterapi almış ve tedavisini tamamlayarak, kür elde edilmiş olan, altmışüç yaşında erkek hasta öksürük ve kanlı balgam şikayeti ile servisimize yatırıldı. Fizik muayenesinde sol hemitoraksta sağa göre solunum sesleri az alındı. Akciğer grafisi ve toraks BT’ de sol hiler bölgede, 6x5x5cm çaplı, malign görünümlü, hiler vasküler yapılara invaze kitle lezyonu izlendi. Hastaya bronkoskopi yapıldı ve endobronşiyal lezyon izlendi. Biyopsi patoloji sonucu skuamöz hücreli karsinom olarak raporlandı. Hastaya evre 3B akciğer karsinomu tanısı ile kemoterapi ve radyoterapi uygulandı ve halen tedavisi sürmektedir. Aynı hastada lenfoma, MALToma ve karsinoma birlikteliğinin nadir görülmesi nedeniyle, literatür bilgileri eşliğinde sunmayı uygun bulduk.

🔖

Cite This Article

GÜLER, A., YALNIZ, E., ÖZDEN, E. P., KARARMAZ, E. A., TEKGÜL, S., TAŞDÖĞEN, N., DİNÇ, Z. A., BAYOL, Ü. (2010). One patient, three malignancy:Hodgkin lymphoma, maltoma, lung cancer. Türk Toraks Dergisi, Cilt: 11 - Sayı: 4, 187–190. https://ajindex.com/articles/328753

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Yamada T, Shinohara K, Takeda K, et al. Second lung adenocarcinoma after combination chemotherapy in two patients with primary Non-Hodgkin’s lymphoma. Jpn J Clin Oncol 1999;29:226-8
  2. Pedersen-Bjergaard J, Larsen SO. Incidence of acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin’s disease. N Engl J Med 1982;307:965-71
  3. Lorigan P, Radford J, Howell A, Thatcher. Lung cancer after treatment for Hodgkin’s lymphoma: a systematic review. Lancet Oncol 2005;6:773-9
  4. Ng AK, Bernardo MVP, Wellwer E, et al. Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long term risks and risk factors. Am J Hematol 2002;100:1989-96
  5. Rueffer U, Josting A, Franklin J, et al. Non-Hodgkin’s lymphoma after primary Hodgkin’s disease in the German Hodgkin’s lymphoma study group: incidence, treatment, and prognosis:American Society of Clinical Oncology. J Clin Oncol 2001;7:2026-32
  6. Swerdlow AJ, Schoemaker MJ, Allerton R, et al. Lung cancer after Hodgkin’ s disease: A nested case-control study of the relation to treatment. American Society of Clinical Oncology. J Clin Oncol 2001;6:1610-8
  7. Oliphant L, McFadden RG. Lung cancer following therapy for Hodgkin’s disease. CMAJ 1985;132:533-5
  8. Mudie NY, Swerdlow AJ, Higgins CD, et al. Risk of second malignancy after Non-Hodgkin’ s lymphoma: A British Cohort Study: American Society of Clinical Oncology. J Clin Oncol 2006;24:1568-74
  9. Boice JD Jr. Second cancer after Hodgkin’s disease- the price of success? J Nati Cancer Inst 1993;85:4-5
  10. Dores G, Metayer C, Curtis R, et al. Second malignant neoplasms among long term survivors of Hodgkin’s disease: a population- based evaluationover 25 years. J Clin Oncol 2002;16:3484-92
  11. Çelik A, Kulun S, Fen T, ve ark. Lenfoma nedeniyle uygulanan radyoterapi sonrası sekonder maligniteler-Olgu Sunumu. Marmara Medical Journal 2006;19:80 5
  12. Travis LB, Gospodarowicz M, Curtis RE, et al. Lung cancer following chemotherapy and radiotherapy for Hodgkin’s disease. J Nati Cancer Inst 2002;94:182-92
  13. Sopori ML, Kozak W. Immunomodulatory effects of cigarette smoke. J.Neuroimmunol 1998;83:148-56.